AFC-HD AMS Life Science Co., Ltd. (2927.T)
JPY 806.0
(-0.86%)
JPY 806.0
(-0.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 25.57 Billion | 22.99 Billion | 22.36 Billion | 15.81 Billion | 16.25 Billion | 15.79 Billion |
| Cost of Revenue | 16.25 Billion | 14.41 Billion | 15.5 Billion | 11.26 Billion | 11.73 Billion | 11.2 Billion |
| Gross Profit | 9.32 Billion | 8.57 Billion | 6.86 Billion | 4.55 Billion | 4.52 Billion | 4.59 Billion |
| Operating Expenses | 7.68 Billion | 7.56 Billion | 4.61 Billion | 3.46 Billion | 3.53 Billion | 3.56 Billion |
| Selling, General and Administrative Expenses | 7.38 Billion | 7.26 Billion | 4.41 Billion | 3.34 Billion | 3.38 Billion | 3.42 Billion |
| Research and Development Expenses | - | 153.02 Million | 163.7 Million | 166.35 Million | 156.62 Million | 139.18 Million |
| Other Expenses | 7.68 Billion | 7.56 Billion | 4.61 Billion | 3.46 Billion | 3.53 Billion | 12.63 Million |
| Cost and Expenses | 23.94 Billion | 21.98 Billion | 20.12 Billion | 14.72 Billion | 15.27 Billion | 14.77 Billion |
| Operating Income | 1.63 Billion | 1.38 Billion | 2.24 Billion | 1.09 Billion | 981.27 Million | 1.02 Billion |
| Interest Expense | 57.55 Million | 57.59 Million | 50.04 Million | 32.92 Million | 36.51 Million | 57.84 Million |
| Income Tax Expense | 439.35 Million | 497.92 Million | 662.35 Million | 327.65 Million | 307.73 Million | 248.97 Million |
| Earnings before Tax | 1.54 Billion | 1.23 Billion | 2.15 Billion | 1 Billion | 1.09 Billion | 985.65 Million |
| Net Income | 1.1 Billion | 735.35 Million | 1.49 Billion | 676.68 Million | 783.29 Million | 736.68 Million |
| Earnings Per Share Basic | 78.51 | 52.33 | 107.12 | 48.12 | 55.70 | 58.28 |
| Earnings Per Share Diluted | 78.46 | 52.08 | 106.30 | 48.12 | 55.70 | 58.28 |
| Weighted Average Shares Outstanding | 14.04 Million | 14.05 Million | 13.96 Million | 14.06 Million | 14.06 Million | 12.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.05 Million | 14.11 Million | 14.06 Million | 14.06 Million | 14.06 Million | 12.63 Million |
| Gross Margin | 0.36 | 0.37 | 0.31 | 0.29 | 0.28 | 0.29 |
| EBIT Margin | 0.10 | 0.10 | 0.13 | 0.10 | 0.09 | 0.09 |
| Profit Margin | 0.04 | 0.03 | 0.07 | 0.04 | 0.05 | 0.05 |
| EBITDA | 2.58 Billion | 2.29 Billion | 2.85 Billion | 1.54 Billion | 1.6 Billion | 1.48 Billion |
| Earnings Before Tax Margin | 0.06 | 0.06 | 0.10 | 0.07 | 0.06 | 0.06 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 7.8 Billion | 7.75 Billion | 6.78 Billion | 25.57 Billion | 6.88 Billion | 6.25 Billion |
| Cost of Revenue | 5.24 Billion | 5.02 Billion | 4.32 Billion | 16.25 Billion | 4.44 Billion | 4.03 Billion |
| Gross Profit | 2.55 Billion | 2.73 Billion | 2.46 Billion | 9.32 Billion | 2.43 Billion | 2.21 Billion |
| Operating Expenses | 2.08 Billion | 2.18 Billion | 1.98 Billion | 7.68 Billion | 1.85 Billion | 1.83 Billion |
| Selling, General and Administrative Expenses | 2.04 Billion | 2.14 Billion | 1.9 Billion | - | 1.77 Billion | 1.76 Billion |
| Research and Development Expenses | 36.37 Million | 37.19 Million | 37.87 Million | - | 38.41 Million | 35.95 Million |
| Other Expenses | -7.6 Million | 4.48 Million | 4.59 Million | 23.22 Million | -11.21 Million | 1.83 Billion |
| Cost and Expenses | 7.32 Billion | 7.21 Billion | 6.3 Billion | 23.94 Billion | 6.3 Billion | 5.87 Billion |
| Operating Income | 472.24 Million | 544.51 Million | 478.94 Million | 1.63 Billion | 582.23 Million | 375.75 Million |
| Interest Expense | 28.85 Million | 21.95 Million | 17.55 Million | 57.55 Million | 15.28 Million | 14.96 Million |
| Income Tax Expense | 173.05 Million | 234.43 Million | 157.8 Million | 439.35 Million | 136.09 Million | 103.76 Million |
| Earnings before Tax | 454.49 Million | 556.61 Million | 477.16 Million | 1.54 Billion | 557.78 Million | 371.99 Million |
| Net Income | 281.21 Million | 323.08 Million | 318.51 Million | 1.1 Billion | 420.52 Million | 267.98 Million |
| Earnings Per Share Basic | 20.00 | 22.99 | 22.80 | - | 30.05 | 19.04 |
| Earnings Per Share Diluted | 19.97 | 22.95 | 22.79 | - | 29.96 | 19.04 |
| Weighted Average Shares Outstanding | 14.06 Million | 14.05 Million | 13.97 Million | 14.04 Million | 13.99 Million | 14.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.08 Million | 14.07 Million | 13.97 Million | 14.05 Million | 14.03 Million | 14.07 Million |
| Gross Margin | 0.33 | 0.35 | 0.36 | 0.36 | 0.35 | 0.35 |
| EBIT Margin | 0.10 | 0.11 | 0.07 | - | 0.08 | 0.06 |
| Profit Margin | 0.04 | 0.04 | 0.05 | 0.04 | 0.06 | 0.04 |
| EBITDA | 761.25 Million | 825.82 Million | 486.75 Million | - | 576.19 Million | 381.5 Million |
| Earnings Before Tax Margin | 0.06 | 0.07 | 0.07 | 0.06 | 0.08 | 0.06 |
3406
OLYMPTX
CHVKF
HLLPF
HALKB
FBRT